UK warned of a ‘stroke crisis’
The UK is at risk of developing a stroke crisis as risk factors for the condition are under-diagnosed and under-treated.
Read MoreAuthor: Katrina Megget
Business managers make it to the top
Business Managers from Lundbeck, LEO Pharma, Shire and Quintiles have shown how they are successfully negotiating the changing healthcare environment and developing new relationships with the NHS by winning PharmaTimes’ Business Manager of the Year competition last night at the Royal College of Physicians.
Read MorePharmaxis’ Bronchitol next cystic fibrosis drug to get the nod
The UK’s drugs watchdog has given another cystic fibrosis drug the thumbs up for NHS use this week – this time for Pharmaxis’ Bronchitol (mannitol dry power).
Read MoreLilly rep competition breaches code
Lilly has been found in breach of the Code of Practice after it was revealed the company implemented an incentive competition for representatives.
Read MoreMedImmune collaborates for cancer immunotherapy trials
AstraZeneca’s biologics arm, MedImmune, is joining forces with two cancer organisations in a bid to advance the research of immunotherapy in cancer.
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
